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One of the characteristics of the host defense of insects is the rapid
synthesis of a variety of potent antibacterial and antifungal pep-
tides. To date, seven types of inducible antimicrobial peptides
(AMPs) have been characterized in Drosophila. The importance of
these peptides in host defense is supported by the observation that
flies deficient for the Toll or Immune deficiency (Imd) pathway,
which affects AMP gene expression, are extremely susceptible to
microbial infection. Here we have developed a genetic approach to
address the functional relevance of a defined antifungal or anti-
bacterial peptide in the host defense of Drosophila adults. We have
expressed AMP genes via the control of the UASGAL4 system in
imd; spa¨tzle double mutants that do not express any known
endogenous AMP gene. Our results clearly show that constitutive
expression of a single peptide in some cases is sufficient to rescue
imd; spa¨tzle susceptibility to microbial infection, highlighting the
important role of AMPs in Drosophila adult host defense.
Antimicrobial peptides (AMPs) are a key component ofinnate immunity. Their distribution throughout the animal
and plant kingdom is ubiquitous, reflecting the importance of
these molecules in host defense (1, 2). In insects, systemic
infection induces the synthesis of combinations of AMPs that are
secreted from the immune organs, mainly the fat body, an
analogue of the mammalian liver, into the hemolymph, where
they reach high concentrations. In Drosophila, at least seven
types of AMPs (plus isoforms) have been described (3–5). Their
activities have been either determined in vitro by using peptides
directly purified from flies or produced in heterologous systems,
or deduced by comparison with homologous peptides isolated in
other insect species: (i) Drosomycin and Metchnikowin show
antifungal activity (6, 7); (ii) Cecropins have both antibacterial
and antifungal activities (8); (iii) Drosocin and Defensin are
predominantly active against Gram-negative and -positive bac-
teria, respectively (9, 10); and (iv) Attacins and Diptericins are
similar to peptides from other insects that show antibacterial
activity (11, 12).
Analysis of the in vivo roles of each AMP on microbial infection
is complicated by the numerous AMP genes present in the fly, as
well as the redundant defense mechanisms within the innate
immune system. The importance of AMPs, however, is supported
by the sensitive phenotype of mutants that do not express AMP-
encoding genes (13–15). A clear correlation is observed between
the lack of expression of antibacterial peptide genes in mutants of
the Immune deficiency (Imd) pathway and their susceptibility to
Gram-negative bacteria (13). Conversely, mutations in the Toll
pathway block Drosomycin expression and result in susceptibility to
fungal infection (14). Finally, mutants deficient in both the Imd and
Toll pathways failed to express any known AMP genes after
infection and are extremely susceptible to both fungal and bacterial
infections (14). These evidences of the importance of AMPs in
fighting infection, however, are still indirect, because we cannot
exclude that these mutations affect other defense reactions. The
Toll pathway, for example, has also been reported to regulate
hemocyte proliferation (16). To study unambiguously the in vivo
role of each AMP in Drosophila host defense, we have generated
imd; spa¨tzle (spz) flies deficient for both the Imd and Toll pathways
but that constitutively express different AMPs under the control of
a noninducible promoter. These flies express only one AMP on
infection and, consequently, we can use a simple survival experi-
ment to monitor the contribution of this peptide in resistance to
infection by various microorganisms. This powerful assay allowed
us to analyze, in vivo, the spectrum of activity of each peptide and,
by combining two different transgenes, any potential synergy
among them. Our results clearly show that expression of a single
peptide, in some cases, is sufficient to rescue the imd; spz suscep-
tibility to microbial infection, highlighting the important role of
AMPs in Drosophila adult host defense.
Materials and Methods
Plasmids. The fusion constructs used for P-element-mediated trans-
formation were: UAS-Drs, which contains a 691-bp BamHI-XbaI
Drosomycin fragment of the gene (6) inserted between the pUAST
BglII-XbaI sites; UAS-Def, which contains a 398-bp HindIII-KpnI
fragment of the Defensin gene (9) inserted between the pUAST
BglII (blunted)-KpnI sites; UAS-Cec A, which contains a 459-bp
EcoRV-XbaI fragment of pSK-Cecropin A (17) inserted between
the pUAST BglII (blunted)-XbaI sites; UAS-Att A, which contains
a 894-bp BamHI-KpnI fragment of pSK-Attacin A (12) inserted
between the pUAST BglII-KpnI sites; UAS-Dpt, which contains a
350-bp EcoRI-EcoRI fragment of the Diptericin gene (11) inserted
in the pUAST EcoRI site; and UAS-Drc, which contains a 347-bp
EcoRI-KpnI fragment of the Drosocin gene (10) inserted between
the pUAST EcoRI-KpnI sites.
Fly Stocks. Fly cultures and crosses were grown on standard fly
medium at 25°C. Oregon R flies were used as wild-type standard.
spzrm7 is a strong mutation in the spa¨tzle gene that encodes the
putative Toll ligand (18). Flies homozygous for spzrm7 failed to
express the Drosomycin gene after septic injury and are highly
susceptible to fungal infection (14). Flies homozygous for imd failed
to express antibacterial peptide genes after septic injury and are
highly susceptible to Gram-negative bacterial infection (13). The
da-GAL4 driver expresses GAL4 ubiquitously and strongly (19).
w1118 flies were used as recipients for transformation, and trans-
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genic lines were established as described (20). We obtained at least
two independent lines for each UAS-Pep construct, with transposon
located on the autosomes. By standard crosses and recombination,
we generated UAS-Pep fly lines of the following genotype: w; imd,
UAS-Pepximd, UAS-Pepx; spzrm7, UAS-PepyTM6C. These flies
were crossed with w; imdimd; da-Gal4, spzrm7TM6C flies to
obtain the flies [w; imd, UAS-Pepximd; spzrm7, UAS-Pep(x or y)da-
GAL4, spzrm7] that we used in our survival experiments.
Microorganisms. Bacteria were precultured in LB medium, with the
exceptions of Staphyloccocus aureus and Agrobacterium tumefaciens,
which were cultured in brain heart infusion (Difco) and yeast
extractpeptone media, respectively. The following are the bacterial
strains used in this study: Pseudomonas aeruginosa (CFBP2466),
Escherichia coli (MG1655), A. tumefaciens (EHA 105); Erwinia
carotovora (21), S. aureus (gifts from H. Monteil, University of
Strasbourg, Strasbourg, France); Bacillus subtilis (168), Microccocus
luteus (gifts from J. Millet and A. Klier, Pasteur Institute, Paris).
Fungi were grown on malt–agar medium with the exceptions of
Neurospora crassa and Fusarium oxysporum, which were cultured on
12 potato dextrose agar and on 6CA medium, respectively. Spores
and hyphae were harvested as described in ref. 22. The strains used
in this study were: F. oxysporum (MUCL 909), N. crassa (CBS
327–54), Beauvaria bassiana (80.2), and Aspergillus fumigatus (gift
from A. Brakhage, Technische Universita¨t, Darmstadt, Germany).
Northern Blot Analysis. Total RNA extraction and Northern blot
experiments were performed as described in ref. 23.
Mass Spectrophotometer. A PerSeptive Biosystems (Framingham,
MA) Voyager Eite matrix-assisted spectrometer was used with laser
desorption time-of-f light with delayed extraction and high-
sensitivity linear detector (24). Ten UAS-Drs imd; spzrm7 adults were
bled with a hand-pulled capillary to collect hemolymph directly into
0.1% trifluoroacetic acidacetonitrile (1:1 volvol). Zip-Tip (Mil-
lipore) was used to purify the hemolymph sample according to the
manufacturer’s protocol. Final resuspension was in 25% acetoni-
trile (total 10l), and 2.5l was spotted on a glass plate for analysis.
Survival Experiments. Microbial challenge was performed by prick-
ing adult flies in the thorax with a sharpened tungsten needle (0.2
mm) dipped into a concentrated bacterial or fungal pellet. Natural
infections with B. bassiana were performed by shaking anesthetized
flies for 30 sec in a Petri dish containing a sporulating fungal culture
(23). Survival experiments were carried out in the same conditions
for each line tested. Three groups of 20 young adults from each line
were challenged, then incubated at 29°C and transferred to fresh
vials every 3 days. Flies that died within the first hour of challenge
were not considered in the analysis. The number of bacteria injected
was estimated by crushing five flies immediately after bacterial
challenge (or clean septic injury for control) in LB medium under
sterile conditions and plating in appropriate dilutions on LB plates.
For more information, see ref. 22.
Results
Generation of Fly Lines That Express One Single AMP. We used the
UASGAL4 system (25) to construct f lies that constitutively
express a single AMP gene. We generated fly lines that carry a
P transgene containing a fusion between the cDNA of each of
the six AMP genes (Diptericin, Drosocin, Cecropin A, Attacin A,
Drosomycin, and Defensin) under the control of the binding sites
for the GAL4 transactivator (referred to as UAS-Pep). To drive
the expression of the UAS-Pep construct, we used daughterless
(da)-GAL4 that produces GAL4 protein ubiquitously to high
levels. We then recombined each of the UAS-Pep and da-GAL4
with either the imd or spz mutation. By standard genetic crosses,
we generated imd; spz double mutant flies carrying two copies
of a UAS-Pep and one copy of da-GAL4 (referred to as
UAS-Pepx, imd;UAS-Pepx, spz). imd; spz double mutant flies, as
previously reported, do not express any of the known AMP genes
(Fig. 1A). In contrast, UAS-Pepx, imd; UAS-Pepx, spz f lies con-
Fig. 1. Generation of imd; spz flies that express one or two AMP genes. (A)
Northern blot analysis showing that imd; spz flies carrying two copies of UAS-Pep
and the da-GAL4 driver produce only the intended AMP genes. Total RNA was
collectedfromwild-type, imdimd; spz,da-GAL4spz,da-GAL4or imd,UAS-Pepx
imd; spz. UAS-Pepx or UAS-Pepyspz, da-GAL4 adult flies either unchallenged (UC)
or 6 h after injection of E. coli and M. luteus (6 h). In contrast to wild-type, imd;
spz flies express no AMP genes after bacterial challenge. imd; spz flies carrying
both the UAS-Pep (UAS-Drs, UAS-Def, UAS-Drc, or UAS-Cec A; data not shown for
the others) and da-GAL4 express only the UAS-Pep-derived transcript (arrows).
The additional sequences of the UAS-Pep fusion construct result in a transcript
with lowermobility thanthatgeneratedbytheendogenousgenes (arrowheads).
The blot was successively probed with Drosomycin (Drs), Defensin (Def ), Cecropin
A1 (CecA), Drosocin (Drc), and ribosomal protein 49 (rp49) as loading control. (B)
ThequantificationofAMPgeneexpressionshowsthatfliescarryingtwoUAS-Pep
insertions and da-GAL4 express the UAS-Pep fusion transcript (solid bar) at a level
comparable to the level observed in 6-h bacterial-challenged wild-type flies
(striped bar). The two exceptions are Diptericin and Defensin, which are ex-
pressed at 30 and 220% of the wild-type level, respectively. The signals from a
Northern blot performed as in A were quantified by a Bio-Imager system, and the
levels of AMP gene expression were normalized by the corresponding values of
the rp49 signal. This experiment was repeated and yielded similar results. (C)
Differential matrix-assisted laser desorption ionization time-of-flight analysis of
hemolymph from imd; spz adult flies carrying both UAS-Drs and da-GAL4 col-
lected in the absence of infection. A unique peak at the exact molecular mass of
the putative Drosomycin is observed in flies overexpressing the UAS-Drs.






stitutively produce UAS-Pep-derived AMP [Fig. 1 A for UAS-
Drosomycin (Drs), UAS-Cecropin A (Cec A), and UAS-Defensin
(Def ); data are not shown for others]. Importantly, Fig. 1 A and
B show that the levels of AMP gene expression in flies carrying
two copies of UAS-Pep and one copy of da-GAL4 were similar
to those observed in 6-h bacterial-challenged wild-type flies. The
two exceptions are the UAS-Diptericin (Dpt) and UAS-Def
constructs, which are expressed to approximately 30 and 200%
of the respective endogenous gene after infection. The endog-
enous Defensin has been reported to express at lower levels after
bacterial injection than the other AMP genes (9). Thus, the
2-fold higher levels of expression of UAS-Def suggest that the
UAS-Pep lines (except UAS-Dpt) are expressed to similar levels.
To test for potential synergy between two peptides, we also
constructed a series of imd; spz lines that contained two different
UAS-Pep constructs and a da-GAL4 driver (referred to as UAS-
Pepx, imd;UAS-Pepy, spz). Fig. 1A shows an illustration of imd; spz
flies that express either Defensin and Cecropin A or Defensin and
Drosocin. All of the UAS-Pep flies that we generated exhibited a
wild-type viability, even though da-GAL4 is reported to have strong
and ubiquitous expression throughout all developmental stages of
Drosophila (19). This observation indicates that chronic expression
of AMP genes is not harmful to the flies.
To ascertain that AMPs can indeed be made by the UAS
GAL4 expression system, we have monitored by matrix-assisted
laser desorption ionization time of flight in the presence of
Drosomycin from imd; spz adult f lies carrying two copies of
UAS-Drs and da-GAL4. We show that flies expressing Droso-
mycin via UASGAL4 display a unique peak at 4,889.2 mass
units that corresponds exactly to the calculated mass of Droso-
mycin. The absence of this peak in wild-type control f lies (data
not shown) indicates that the expected peptide was produced by
the UASGAL4 system. These data also demonstrate that
posttranscriptional mechanisms that might control Drosomycin
maturation do not depend on either the Imd or Toll pathway.
Resistance Against Gram-Positive Bacterial Infection. In a first set of
experiments, we compared the survival rate of wild-type, imd;
spz and UAS-Pepx imd; UAS-Pep(x or y), spz f lies after injection by
three Gram-positive bacterial species: M. luteus, S. aureus, and B.
subtilis. Fig. 2 A–C Left show the survival curve of flies express-
ing a single peptide over 5 days. A–C Right display the percentage
of survival at one critical time point for all of the UAS-Pep
combinations that we tested.
Fig. 2A shows that infection by M. luteus does not affect the
viability of wild-type flies but reproducibly kills 90% of the imd; spz
double mutant within 5 days. imd; spz flies overexpressing Defensin
show a wild-type survival after infection by M. luteus, whereas most
other peptide-expressing flies survived at less than 25% after 3 days.
This result corroborates previous in vitro data showing that Defen-
sin has strong activity against Gram-positive bacterial species (9)
(26). In addition, the expression of Drosocin confers a weak
protection against M. luteus (32% survival compared with 5–10%
survival) by other lines after 5 days, which is also in agreement with
previous in vitro studies (10) (Fig. 2A). Flies expressing Drosocin in
combination with either Drosomycin or Diptericin display an in-
creased resistance against this Gram-positive bacterium, suggesting
a potential cooperative effect between these peptides (Fig. 2A
Right).
We repeated this analysis by using B. subtilis and S. aureus. Fig.
2 B and C show that these two bacteria are highly pathogenic for
wild-type adults. However, the observation that imd; spz double
mutants succumb faster than wild-type flies indicates that the
inducible immune response provides some defense against these
pathogens. The overexpression of Defensin in imd; spz mutants
provides resistance against these two Gram-positive bacteria to
levels higher than those of wild-type flies (Fig. 2 B and C).
Overexpression of a single copy of UAS-Def provides a complete
resistance to B. subtilis, whereas wild-type flies succumb in less than
48 h (Fig. 2B Left), suggesting that the accumulation of Defensin
produced constitutively via the UASGAL4 system before infec-
tion is critical for eliminating B. subtilis cells injected into the host.
Fig. 2C shows that Defensin overexpression significantly delays the
death of flies infected by S. aureus. We attempted to increase
Drosophila resistance to this pathogenic bacterium by generating
imd; spz adults carrying three copies of UAS-Def. Fig. 2C shows a
clear correlation between the survival rate after infection by S.
aureus and the number of UAS-Def copies, indicating a dose-
dependent activity of Defensin. Despite the high level of Defensin
expression, however, all of the flies succumbed to this infection.
Finally, the protective effect induced by Defensin overexpression is
not enhanced in the presence of other AMPs (Fig. 2 A–C Left).
Resistance Against Gram-Negative Bacterial Infection. We repeated
this analysis by using four Gram-negative bacterial species: E.
coli, E. carotovora, A. tumefaciens, and P. aeruginosa. Infection by
E. coli or E. carotovora, two bacterial species of the Enterobac-
teriaceae family, does not affect the viability of wild-type adults
Fig. 2. Immune-compromised flies overexpressing the Defensin gene resist
as wild type to Gram-positive bacterial infection. The survival rates (expressed
in percentage) of wild-type, imd; spz and imd; spz UAS-Pep flies after infection
by three Gram-positive bacteria are shown. Sixty flies of each line aged 2–5
days were pricked by a needle dipped into a pellet (OD60050) of (A) M. luteus
(400 bacteriafly), (B) B. subtilis (400 bacteriafly), or (C) S. aureus (300
bacteriafly). (Left) Survival curve of the flies that express only one single
peptide (UAS-PepX, UAS-PepX) over a 5-day time course. (Right) Survival rate
at one or two critical time point(s) for all of the UAS-Pep combinations that we
tested (UAS-PepX,UAS-PepY). The survival rate was also monitored on flies
carrying three copies of UAS-Def in combination with da-GAL4 (referred to as
Def; Def; Def ). The precise genotype of flies indicated below each bar as Pepx;
Pepy was w; imd, UAS-Pepximd; spzrm7, UAS-Pepyspzrm7, da-GAL4.
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but does kill imd; spz double mutants within 72 and 48 h after
infection, respectively (Fig. 3 A and B). Attacin A expression
significantly increases the resistance of imd; spz double mutant
flies to these bacteria. At 24 h after infection, 50–75% of the imd;
spz f lies expressing Attacin A survive, whereas the imd; spz f lies
are nearly all dead. Drosocin and Diptericin expression conferred
a weak protection against E. coli. Fig. 3 A and B Left, however,
show that coexpression of Attacin A with either Diptericin or
Drosocin provides a better resistance to E. coli and E. carotovora
than the single peptide or other combinations. This observation
suggests that Diptericin and Drosocin may cooperate with
Attacin A to combat some Gram-negative bacteria.
In contrast, Drosocin expression, but not Attacin A, increases
slightly but significantly the resistance against A. tumefaciens
(25% survived compared with 0% shown by other AMPs at 48 h
after infection), demonstrating the differences between the
activities of these two peptides (Fig. 3C). Our data indicate that
the protective effect against A. tumefaciens by Drosocin expres-
sion requires two UAS-Drc copies. In addition, Drosocin coex-
pression with Attacin A (but not with Cecropin A or Drosomycin)
provides enhanced protection against this bacterium.
P. aeruginosa, a human opportunistic pathogen, is highly patho-
genic to Drosophila (27). Fig. 3D shows that injection of a few P.
aeruginosa cells kills wild-type flies in less than 16 h. Surprisingly,
imd; spz flies succumb with the same kinetics, suggesting that either
this bacterium can exert its pathogenic effect before the induction
of an immune response or the Drosophila immune response is
inefficient against this species. Our analysis shows that the consti-
tutive expression of AMPs does not confer any significant protec-
tion against P. aeruginosa, suggesting that this bacterium is more
resistant to AMPs than the other three Gram-negative bacteria that
we tested. Cecropin A, Attacin A, and Diptericin provide a weak
protection to the infected flies (Fig. 3D Left).
Resistance to Fungal Infection. We next repeated our analysis by
using three different fungal species: N. crassa, F. oxysporum, and A.
fumigatus. Fig. 4 A–C show that Drosomycin was the most potent
antifungal peptide (6). Drosomycin expression in imd; spz mutants
restores a wild-type level of survival against both N. crassa and F.
oxysporum and an increased resistance to A. fumigatus. The en-
hanced resistance to F. oxysporum and, to a lesser extent, A.
fumigatus was observed in the lines carrying two UAS-Drs but not
in the lines carrying one copy, suggesting that the concentration of
this antifungal peptide must be above a certain threshold to be
effective. In contrast to imd; spz mutants, N. crassa did not sporulate
on imd; spz flies expressing Drosomycin that died after infection
(Fig. 5), indicating that the high concentration of Drosomycin in the
dead flies may also limit the sporulation and spread of this fungus.
Furthermore, flies carrying one copy of UAS-Drs show resistance
to F. oxysporum when coexpressed with Cecropin A (Fig. 4B Left),
a peptide that has been shown to have antifungal activity (8). Flies
expressing Defensin and, to a lesser extent, Diptericin and Drosocin
all show increased resistance to F. oxysporum.
B. bassiana is a fungal entomopathogen that infects through the
insect cuticle. Previous experiments have indicated the existence of
a Toll-dependent host-defense reaction against this fungus, because
Toll-deficient mutants survived B. bassiana infection at lower levels
than wild-type flies (23). We have monitored the survival of the
different UAS-Pep lines after deposition of spores on fly cuticle, in
contrast to the preceding experiments in which microbes are
injected by a needle. Fig. 4D shows that natural infection by this
fungus kills all of the imd; spz double mutants in less than 72 h,
whereas wild-type flies succumb at a slower rate (40% survived at
6 days after infection). Surprisingly, none of the UAS-Pep-
expressing lines resisted B. bassiana infection better than imd; spz
flies (Fig. 4D), suggesting that the Toll-mediated defense response
to this fungus involves other AMP combinations or a yet unchar-
acterized defense reaction.
Discussion
Most of our knowledge of Drosophila AMP activity has come
from studies performed in vitro. Although these studies have
been successful in identifying the specificity and mode of action
of some AMPs, they do not fully measure the in vivo role of each
AMP in fighting infections. Here, we developed a genetic
approach to address the functional relevance of a defined AMP
in the host defense of Drosophila adults. We take advantage of
the imd; spz double mutants that do not express any known
endogenous AMP genes to generate immuno-compromised flies
that express only one or two AMPs, even after infection. We
show that constitutive expression of a single AMP gene such as
Drosomycin or Defensin can confer a wild-type resistance to these
otherwise immunodeficient flies against certain microorgan-
isms. These results provide strong support for a critical role of
AMPs in surviving infections in Drosophila, taking into account
Fig. 3. Immune-compromised flies expressing Attacin A show increased
resistance after infection by Gram-negative bacterial species. The survival
rates of wild-type, imd; spz and imd; spz UAS-Pep-expressing flies after
infection by four Gram-negative bacteria are shown. Sixty flies were treated
as described in the legend to Fig. 2 with a pellet of (A) E. coli (pellet OD600 
20,400 bacteriafly), (B) E. caratovora (pellet OD60020,560 bacteriafly),
(C) A. tumefaciens (pellet OD600  20, 300 bacteriafly), and (D) P. aerugi-
nosa (pellet OD600  0.2, 70 bacteriafly). Because P. aeruginosa is a fast-
acting pathogen, the survival curve is represented by a shorter time interval.






that the wild-type antimicrobial response involves the concom-
itant synthesis of about 15 inducible AMP genes.
In our assay, the AMP genes are expressed via the UAS
GAL4 system at a level similar to that observed in wild-type
induction of the endogenous AMP genes (except Defensin and
Diptericin). However, there are still some differences between
our assay and the wild-type physiological condition. In the
UAS-Pep f lies, AMP genes are expressed ubiquitously and
constitutively, contrasting to the wild-type flies in which peptides
are made mainly by the fat body in an acute phase profile. The
accumulation of AMP, therefore, through constitutive gene
expression before infection may be critical to confer an effective
protection. It is noteworthy that Defensin and Drosomycin, the
two most potent AMPs shown by our analysis, contain three and
four internal disulfide bonds, respectively, that may confer
an increased resistance to proteases, resulting in more stable
peptides.
Our study provides an alternative method for monitoring and
comparing the antimicrobial activity of the various Drosophila
AMPs. We show that Defensin is the most potent peptide against
Gram-positive bacteria (Fig. 2), whereas Attacin A and Drosomycin
are active against Gram-negative bacteria and fungi, respectively
(Figs. 3 and 4). We observe that one copy of UAS-Def is sufficient
to protect flies to wild-type level against M. luteus, B. subtilis, and
S. aureus. The efficiency of Defensin may explain why the endog-
enous Defensin gene is transcribed to lower levels than the other
AMP genes after infection (9). We also observe that one copy of
UAS-Drs was sufficient to protect against N. crassa, whereas two
copies are required to induce a complete and partial protection
against F. oxysporum and A. fumigatus, respectively. These results
are consistent with the Minimum Inhibitory Concentration assay of
Drosomycin required in vitro to kill these three fungi: 0.3–0.6 M
for N. crassa, 1.2–2.5 M for F. oxysporum, and 20–40 M for A.
fumigatus (28). In addition, we show, to our knowledge for the first
time, that Diptericin in Drosophila contributes to resistance against
some Gram-negative bacteria, although its activity is probably
underestimated because of the low levels of Diptericin expression
generated by our constructs. Surprisingly, we did not detect a clear
protective effect of Cecropin A in our assay, whereas this peptide
shows strong in vitro activity (8). We cannot exclude the possibility
that in our lines, Cecropin A was not effectively produced or well
processed to the active form. Alternatively, a higher level of
Cecropin A expression may be required to generate a protective
effect, considering that the Drosophila genome contains three other
inducible Cecropin genes.
Our results also underline the differential activities of Dro-
sophila AMPs, such is the case of Attacin A and Drosocin in
resistance to some Gram-negative bacterial species (Fig. 3). Thus
the existence of numerous AMPs may help widen the protection
against a large number of microorganisms. In the case of
Gram-negative bacterial infection, none of the peptides were
able to restore a wild-type resistance in imd; spz double mutants.
Our results and the observation that the Drosophila genome
encodes a high number of AMP genes with activity directed
against Gram-negative bacteria suggest that the elimination of
this class of bacteria may require the global toxicity generated by
multiple, rather than one or two, AMPs.
Our study does not reveal a striking synergistic activity among
any pair of AMPs tested. In some cases, we observed a rather
cooperative effect between two AMPs such as Attacin A when
coexpressed with either Diptericin or Drosocin in resistance to
some Gram-negative bacteria. These observations suggest that
the multiple Drosophila AMPs may function in an additive way,
rather than synergistically.
Host–pathogen interactions are antagonistic relationships in
which the success of each organism depends on its ability to
overcome the other. The production of AMPs is a common strategy
to eliminate the invading microbes and, consequently, pathogens
Fig. 4. Immune-compromised flies expressing Drosomycin show increased
resistance to fungal infection. The survival rates of wild-type, imd; spz and
imd; spz UAS-Pep flies after infection by four fungal species are shown. Sixty
flies were either pricked by a needle dipped into a concentrated pellet of
spores of (A) N. crassa (5.7  1011 sporesml), (B) F. oxysporum (1.8  1011
sporesml), or (C) A. fumigatus (4 1011 sporesml), or (D) naturally infected
by B. bassiana.
Fig. 5. N. crassa does not sporulate on dead flies that expressed the Drosomycin
gene. Injection of N. crassa spores induces fungal sporulation on dead imd; spz
flies (A)butnoton imd; spzflies thatconstitutivelyexpressDrosomycin (B).Visible
germination was photographed 48 h after death of flies.
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have evolved strategies to prevail over these defenses (1). Our assay
provides a powerful tool to compare the resistance of various
bacteria to different AMPs, because in our experiments, microbes
were injected in an environment previously enriched in peptides.
The time race between pathogen and the host defense is clearly
illustrated by our observation that a preexisting level of Defensin is
sufficient to ensure a complete resistance against B. subtilis, a
Gram-positive bacterium highly pathogenic for flies (Fig. 2B). This
observation indicates that this bacterial species is sensitive to
Drosophila AMP but nevertheless can overtake the Drosophila
immune response by its rapid growth. The observation that ‘‘im-
munizing’’ flies with nonpathogenic bacteria fully protects Dro-
sophila from a subsequent infection by B. subtilis (data not shown)
is consistent with this hypothesis. Our results also show that the
kinetics of infection by P. aeruginosa or B. bassiana, two highly
entomopathogenic microbes, were not delayed in flies expressing
AMP genes, suggesting that these microbes have developed some
mechanisms to escape the AMP activity. The observation that
Drosomycin expression does not confer any protection against B.
bassiana is unexpected, because Toll-mediated defense against this
pathogen has been reported (23). This observation suggests that
other antifungal peptides (e.g., Metchnikowin) or a yet uncharac-
terized defense reaction may be required to resist this fungus.
Finally, the human pathogen, S. aureus, is also highly pathogenic to
Drosophila and shows a better resistance to a high level of Defensin
compared with other Gram-positive bacteria. These results under-
line the correlation between pathogenicity and increased resistance
to AMPs.
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